The FDA launched and expanded its PreCheck Pilot Program for manufacturing plants, selecting companies including Eli Lilly, Regeneron, Cellares, and Fujifilm to participate. The program is intended to increase regulatory predictability for sponsors building U.S. facilities by front-loading plant assessments before specific product applications.